ArticleThe Journal of international medical research2018

Short course of simvastatin has no effect on markers of endothelial activation in normolipidemic patients with systemic sclerosis.

Przemyslaw J KotylaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.